In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel treat culture as the soul of an organization and value diversity of thought among employees. They also support instilling guiding principles that can help reduce rulemaking and streamline everyday decisions. The idea of using culture as a strategic weapon is also discussed.
Expanding Immune Response Testing to Support Vaccine Development
April 22nd 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and CAR T cell therapy.
New Insights Into T Cell Exhaustion and Inflammation in Long COVID
April 17th 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight into post-infection immune disruption.